Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S4W-24241 · Session 4

What plans it has to make ponatinib available to patients.

Answered Asked by Nanette Milne Con Lodged 29 Jan 2015

The question

To ask the Scottish Government what plans it has to make ponatinib available to patients.

The answer

Answered by Shona Robison on 4 Feb 2015 · 6 days after it was lodged, on time

The Scottish Medicines Consortium (SMC) is currently considering a submission for ponatinib (Iclusig) for the treatment of adult patients with chronic myeloid leukaemia and Philadelphia chromosome positive active lymphoblastic leukaemia. This submission is eligible for consideration under the new SMC arrangements for end of life, orphan and ultra-orphan medicines. This means there is the option for the additional element of Patient and Clinician Engagement and provides two opportunities for manufacturers to put forward a patient access scheme to improve the cost-effectiveness of a medicine. The SMC plans to publish their advice in April 2015.

In the Official Report

No contribution in the Official Report cites S4W-24241 by reference.